Assignee
STATENS SERUMINSTITUT
DK·38 granted patents·16 pending applications·742 citations·filing 1989–2025
Top patents by PatentIndex Score
54 records- 0193US7749520B2Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipidsSTATENS SERUMINSTITUT·Filed 2005·Granted Jul 6, 2010·23 cites·17 claims
- 0289US5985935ATreatment and prophylaxis of diseases caused by parasites, or bacteriaSTATENS SERUMINSTITUT·Filed 1993·Granted Nov 16, 1999·49 cites·47 claims
- 0388US8703151B2Tuberculosis vaccines comprising antigens expressed during the latent infection phaseSTATENS SERUMINSTITUT·Filed 2012·Granted Apr 22, 2014·7 cites·17 claims
- 0488US6991797B2M. tuberculosis antigensSTATENS SERUMINSTITUT·Filed 2001·Granted Jan 31, 2006·56 cites·13 claims
- 0587US7037510B2Hybrids of M. tuberculosis antigensSTATENS SERUMINSTITUT·Filed 2001·Granted May 2, 2006·35 cites·21 claims
- 0686US6281336B1Process for producing immunoglobulins for intravenous administration and other immunoglobulin productsSTATENS SERUMINSTITUT·Filed 1999·Granted Aug 28, 2001·112 cites·14 claims
- 0785US7138120B2Process for producing immunoglobulins for intravenous administration and other immunoglobulin productsSTATENS SERUMINSTITUT·Filed 2001·Granted Nov 21, 2006·41 cites·15 claims
- 0884US6982085B2TB diagnostic based on antigens from M. tuberculosisSTATENS SERUMINSTITUT·Filed 2002·Granted Jan 3, 2006·19 cites·10 claims
- 0984US6806355B2Purification process for large scale production of Gc-globulin, the Gc-globulin produced hereby, a use of Gc.globulin and a Gc-globulin medicinal productSTATENS SERUMINSTITUT·Filed 2002·Granted Oct 19, 2004·18 cites·12 claims
- 1082US5955077ATuberculosis vaccineSTATENS SERUMINSTITUT·Filed 1995·Granted Sep 21, 1999·95 cites·30 claims
- 1181US10004793B2M.tuberculosis vaccinesSTATENS SERUMINSTITUT·Filed 2015·Granted Jun 26, 2018·3 cites·19 claims
- 1281US7838013B2Specific epitope based immunological diagnosis of tuberculosisSTATENS SERUMINSTITUT·Filed 2005·Granted Nov 23, 2010·12 cites·4 claims
- 1380US10925954B2Vaccines against Chlamydia spSTATENS SERUMINSTITUT·Filed 2018·Granted Feb 23, 2021·1 cites·15 claims
- 1480US6649409B1Method for producing a nucleotide sequence construct with optimized codons for an HIV genetic vaccine based on a primary, early HIV isolate and synthetic envelope BX08 constructsSTATENS SERUMINSTITUT·Filed 2000·Granted Nov 18, 2003·18 cites·48 claims
- 1578US9526773B2M. tuberculosis vaccinesSTATENS SERUMINSTITUT·Filed 2013·Granted Dec 27, 2016·2 cites·17 claims
- 1675US7968105B2Tuberculosis vaccines comprising antigens expressed during the latent infection phaseSTATENS SERUMINSTITUT·Filed 2006·Granted Jun 28, 2011·2 cites·21 claims
- 1775US6649170B1Adjuvant combinations for immunization composition and vaccinesSTATENS SERUMINSTITUT·Filed 1999·Granted Nov 18, 2003·46 cites·10 claims
- 1875US5231168AMalaria antigenSTATENS SERUMINSTITUT·Filed 1989·Granted Jul 27, 1993·64 cites·7 claims
- 1974US7867502B1Tuberculosis vaccine and diagnostics based on the Mycobacterium tuberculosis sat-6 gene familySTATENS SERUMINSTITUT·Filed 2003·Granted Jan 11, 2011·10 cites·22 claims
- 2074US2025255951A1Vaccines against Chlamydia sp.STATENS SERUMINSTITUT·Filed 2025·Application pending·0 cites
- 2173US6641814B1Nucleic acids fragments and polypeptide fragments derived from M. tuberculosisSTATENS SERUMINSTITUT·Filed 1998·Granted Nov 4, 2003·43 cites·43 claims
- 2272US6921808B2Purification process for large scale production of Gc-globulin, the Gc-globulin produced hereby, a use of Gc-globulin and a Gc-globulin medicinal productSTATENS SERUMINSTITUT·Filed 2004·Granted Jul 26, 2005·5 cites·6 claims
- 2368US6429192B1Purification process for production of mannan-binding lectin and an MBL medicinal productSTATENS SERUMINSTITUT·Filed 1999·Granted Aug 6, 2002·33 cites·30 claims
- 2467US6451611B1Quantitative analysis of hexose-monophosphates from biological samplesSTATENS SERUMINSTITUT·Filed 2000·Granted Sep 17, 2002·17 cites·41 claims
- 2566US2021205433A1Vaccines against Chlamydia sp.STATENS SERUMINSTITUT·Filed 2021·Application pending·0 cites
- 2662US7749507B2Malaria vaccineSTATENS SERUMINSTITUT·Filed 2005·Granted Jul 6, 2010·1 cites·5 claims
- 2761US2010015171A1Vaccines comprising tb 10.4STATENS SERUMINSTITUT·Filed 2009·Application pending·0 cites
- 2860US2007184073A1TB diagnostic based on antigens from M. tuberculosisSTATENS SERUMINSTITUT·Filed 2005·Application pending·0 cites
- 2956US2014205656A1Modified cationic liposome adjuvantsSTATENS SERUMINSTITUT·Filed 2014·Application pending·0 cites
- 3056US2025170236A1A novel cationic adjuvant compositionSTATENS SERUMINSTITUT·Filed 2023·Application pending·0 cites
- 3156US2014275478A1Vaccines against Chlamydia sp.STATENS SERUMINSTITUT·Filed 2014·Application pending·0 cites
- 3255US2008299151A1Influenza vaccinesSTATENS SERUMINSTITUT·Filed 2008·Application pending·0 cites
- 3355US2024299528A1A dna plasmid sars-corona virus-2/covid-19 vaccineSTATENS SERUMINSTITUT·Filed 2021·Application pending·0 cites
- 3454US6165997APhospholipids having antimicrobial activity with or without the presence of antimicrobialsSTATENS SERUMINSTITUT·Filed 1998·Granted Dec 26, 2000·18 cites·15 claims
- 3554US2019201340A1Methods for producing liposomesSTATENS SERUMINSTITUT·Filed 2018·Application pending·0 cites
- 3651USRE46583EVaccines comprising TB10.4STATENS SERUMINSTITUT·Filed 2015·Granted Oct 24, 2017·0 cites·23 claims
- 3751US2004086949A1Method for preparing a ligand presenting assembly (LPA), an LPA and uses thereofSTATENS SERUMINSTITUT·Filed 2003·Application pending·0 cites
- 3850US7776821B2Method comprising nanofiltration to obtain an MBL product safe from infectious agents and the product obtainable by this methodSTATENS SERUMINSTITUT·Filed 2005·Granted Aug 17, 2010·0 cites·24 claims
- 3949US10729765B2Alpha-tocopherol-based adjuvanted solvent for DNA vaccinesSTATENS SERUMINSTITUT·Filed 2015·Granted Aug 4, 2020·0 cites·11 claims
- 4049US10519202B2Tuberculosis TB vaccine to prevent reactivationSTATENS SERUMINSTITUT·Filed 2014·Granted Dec 31, 2019·0 cites·4 claims
- 4149US9523131B2PCR diagnostics of dermatophytes and other pathogenic fungiSTATENS SERUMINSTITUT·Filed 2014·Granted Dec 20, 2016·0 cites·10 claims
- 4249US2023225972A1Liposomal composition for preventing or early treatment of pathogenic infectionSTATENS SERUMINSTITUT·Filed 2021·Application pending·0 cites
- 4348US2002094336A1Nucleic acid fragments and polypeptide fragments derived from M. tuberculosisSTATENS SERUMINSTITUT·Filed 2001·Application pending·0 cites
- 4447US10641770B2Diagnostic reagents for improved in vivo or in vitro cell-mediated immunological diagnosis of tuberculosisSTATENS SERUMINSTITUT·Filed 2014·Granted May 5, 2020·0 cites·16 claims
- 4546US10786579B2Skin testing for tuberculosis in immunocompromised personsSTATENS SERUMINSTITUT·Filed 2016·Granted Sep 29, 2020·0 cites·20 claims
- 4646US6120776ADiagnostic skin test for tuberculosisSTATENS SERUMINSTITUT·Filed 1994·Granted Sep 19, 2000·12 cites·50 claims
- 4746US2003065039A1Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-onesSTATENS SERUMINSTITUT·Filed 2002·Application pending·0 cites
- 4843US7678544B2ADAM12, a novel marker for abnormal cell functionSTATENS SERUMINSTITUT·Filed 2005·Granted Mar 16, 2010·0 cites·9 claims
- 4942US2010311041A1Pcr diagnostics of dermatophytes and other pathogenic fungiSTATENS SERUMINSTITUT·Filed 2006·Application pending·0 cites
- 5041US9422348B2Production of a cysteine rich proteinSTATENS SERUMINSTITUT·Filed 2012·Granted Aug 23, 2016·0 cites·20 claims
Showing the top 50 of 54 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →